Immunogen, Inc. [NASDAQ: IMGN] price surged by 31.23 percent to reach at $10.62. The company report on February 1, 2024 at 4:30 PM that ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4). ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug
Immunogen, Inc. [NASDAQ: IMGN] traded at a high on Tuesday, posting a 0.72 gain after which it closed the day’ session at $29.51. The company report on February 1, 2024 at 4:30 PM that ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4). ImmunoGen, Inc.,
Immunogen, Inc. [NASDAQ: IMGN] slipped around -0.03 points on Tuesday, while shares priced at $29.39 at the close of the session, down -0.10%. The company report on January 3, 2024 at 4:30 PM that ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4). ImmunoGen, Inc.,
© 2024, Powered by Smart TechOne
